← Back to Search

Treatment Group for Epilepsy (HOBSCOTCH Trial)

N/A
Waitlist Available
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether a phone intervention called HOBSCOTCH can improve health and quality of life for people with refractory epilepsy.

Eligible Conditions
  • Epilepsy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline & 8-10 weeks after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline & 8-10 weeks after baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Quality of Life in Epilepsy - 31 score
Secondary study objectives
Feasibility of HOBSCOTCH in the clinical setting

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment GroupExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor
181 Previous Clinical Trials
11,049 Total Patients Enrolled
NYU Langone HealthOTHER
1,408 Previous Clinical Trials
855,755 Total Patients Enrolled
26 Trials studying Epilepsy
2,989 Patients Enrolled for Epilepsy
~5 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top